Immune Globulin Subcutaneous (Human)

CHEBI:CHEBI_757021

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Immune Globulin Subcutaneous (Human)
listing_expiration_date
20241231
active_ingredient_strength
200 mg/mL
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
marketing_category
BLA
product_type
PLASMA DERIVATIVE
active_ingredient_name
HUMAN IMMUNOGLOBULIN G
pharm_class
Passively Acquired Immunity [PE]
labeler_name
Takeda Pharmaceuticals America, Inc.
marketing_start_date
20161018
package_marketing_start_date
20161018
brand_name
CUVITRU
brand_name_base
CUVITRU
product_ndc
0944-2850
application_number
BLA125596
spl_id
396f9f8a-a6a3-44ee-8925-2ccb36cbc4fb
package_ndc
0944-2850-09
package_description
1 BOTTLE, GLASS in 1 CARTON (0944-2850-09) / 50 mL in 1 BOTTLE, GLASS (0944-2850-10)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class